The higher BSEP expression level in liver specimens from patients with OTCD after 4PB therapy compared with that before 4PB therapy suggests that 4PB treatment increases BSEP expression in humans[14]. This evidence concerns the gene ABCB11 and ornithine carbamoyltransferase deficiency.